Cardiology, University of South Dakota, Sioux Falls, South Dakota, USA
SUNY Downstate Medical Center Department of Internal Medicine, Brooklyn, New York, USA.
BMJ Case Rep. 2021 Dec 7;14(12):e246223. doi: 10.1136/bcr-2021-246223.
Since the start of the COVID-19 pandemic, several cases have reported extensive multivessel coronary thrombosis as a cardiovascular manifestation of SARS-CoV-2 infection. This case describes a patient who developed non-ST elevation myocardial infarction during hospitalization for acute hypoxic respiratory failure due to COVID-19. We review the immediate and delayed revascularisation strategies of culprit and non-culprit lesions in the setting of high intracoronary thrombus burden induced by SARS-CoV-2. Successful percutaneous intervention and stenting of a culprit lesion and resolution of an intracoronary thrombus using a delayed strategy of lesion passivation with adjuvant pharmacotherapy are demonstrated on index and follow-up angiography.
自 COVID-19 大流行开始以来，已有数例报告称，广泛的多血管冠状动脉血栓形成是 SARS-CoV-2 感染的心血管表现。本病例描述了一名患者，该患者因 COVID-19 导致急性低氧性呼吸衰竭住院期间发生非 ST 段抬高型心肌梗死。我们回顾了在由 SARS-CoV-2 引起的高冠状动脉血栓负荷情况下，罪犯和非罪犯病变的即刻和延迟血运重建策略。通过辅助药物治疗使病变失活的延迟策略成功地对罪犯病变进行经皮介入治疗和支架置入，并在索引和随访血管造影上显示了冠状动脉内血栓的溶解。
